Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

NCT00629278 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

2500

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: aromatase inhibition therapy
DRUG: cyclophosphamide
DRUG: docetaxel
DRUG: doxorubicin hydrochloride
DRUG: epirubicin hydrochloride
DRUG: fluorouracil
DRUG: paclitaxel
DRUG: releasing hormone agonist therapy
DRUG: tamoxifen citrate
PROCEDURE: adjuvant therapy
RADIATION: radiation therapy

Sponsor

Azienda Ospedaliero-Universitaria di Modena